CAS: 17016-83-0; (S)-4-Isopropyl-2-Oxazolidinone

该化合物是一种在不对称合成中广泛使用的手性辅助剂,其硬性oxazolidinone框架有利于高立体选择性反应,如增代和藻类.异丙基组加强了...

结构式图片

相似化合物

95530-58-8 103723-70-2 54705-42-9

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号2026-48-4 L-缬氨醇 | CAS号124-38-9 二氧化碳 | CAS号105-58-8 碳酸二乙酯 | CAS号201230-82-2 carbon monoxide | CAS号599164-44-0 (S)-N-[(3R)-3-m... | CAS号84272-19-5 (4S)-(-)-4-ISOP... | CAS号80697-99-0 (S)-3-((R)-3-(b... | CAS号67-56-1 甲醇 | CAS号186355-83-9 (4S)-3-(2-bromo... | CAS号192329-12-7 (4S)-3-(2-cyclo... | CAS号17016-83-0 (4S)-(-)异丙基-2-恶唑酮 | CAS号95530-58-8 (4R)-(+)-4-异丙基-... | CAS号80697-93-4 (S)-4-(1-Isopro... | CAS号77877-19-1 (|S|)-(+)-4-异丙基... | CAS号16369-05-4 2-氨基-3-甲基-1-丁醇 | CAS号2026-48-4 L-缬氨醇 | CAS号77887-48-0 (N-乙酰基)-(4s)-异丙... | CAS号90719-29-2 (4S)-N-巴豆酰基-4-异...

合成工艺路线路线简述

    L-缬氨酸置于sodium Tetrahydroborate,碘,Potassium Carbonate体系中,用 四氢呋喃 用作溶剂,化学反应 30.5H,反应生成(S)-4-异丙基-2-唑烷酮
    参考文献:海洋大环内酯lytophilippine A的非对映异构体的合成
    标题:海洋大环内酯lytophilippine A的非对映异构体的合成
    摘要:冻干品a的非对映异构体的合成需要使用已知构件的22个最长的线性步骤.交叉复分解/不对称醛醇加成和区域选择性酯化/闭环复分解是构建支架的有效组合工具.在不同溶剂(系统)中进行的详细NMR研究为名为lytophilippine A的分子的根深蒂固的构型错配提供了证据.
    Doi:10.1021/acs.Orglett.9B00722

    海关参考信息

    专利信息


    专利号:US-6350878-B1
    优先权日:1998-05-18
    标 题 :Intermediates for the synthesis of epothilones and methods for their preparation
    发明人:ALTMANN KARL-HEINZ; BAUER ARMIN; SCHINZER DIETER
    权利人:NOVARTIS AG
    摘要:The invention relates to a method of synthesis for a compound of formula (I),wherein R is a heterocyclyl moiety and X1, X2, X3 and X4 are, independently of each other, protecting groups, which is appropriate for the synthesis of epothilone B and desoxyepothione B.

    专利号:US-6849743-B2
    优先权日:1997-08-15
    标 题 :Synthesis of clasto-lactacystin β-lactone and analogs thereof
    发明人:SOUCY FRANCOIS; FLAMONDON LOUIS; BEHNKE MARK; ROUSH WILLIAM
    权利人:MILLENNIUM PHARM INC
    摘要:The present invention is directed to an improved synthesis of clasto-lactacystin-β-lactone, and analogs thereof, that proceeds in fewer steps and in much greater overall yield than syntheses described in the prior art. The synthetic pathway relies upon a novel stereospecific synthesis of an oxazoline intermediate and a unique stereoselective addition of a formyl amide to the oxazoline. Also described are novel clasto-lactacystin-β-lactones, and analogs thereof and their use as proteasome inhibitors.

    专利号:US-6887887-B2
    优先权日:2001-03-19
    标 题:Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor
    发明人:BORNMANN WILLIAM G; SIROTNAK FRANCIS; SCHER HOWARD; VIDAL EPHRAIM; BORELLA CHRISTOPHER; SCHEINBERG DAVID
    权利人:SLOAN KETTERING INST CANCER
    摘要:The present invention provides methods for the asymmetric synthesis of (S,S,R)-(−)-actinonin and its analogs and the compounds thereby synthesized having a structural formula: n n nwhere R 1 is an optionally substituted or halogenated alkyl, aryl, heteroalkyl or heteroaryl amine, said R 1 further comprising a cyclic or bicyclic structure; R 2 is methyl, CH 2 CH 3 , (CH 2 ) 2 CH 3 , C(CH 3 ) 3 , phenyl, 3,4-dichlorophenyl, biphenyl, benzyl, 4-hydroxybenzyl, piperidine, N-Boc-4-piperidine, CH 2 -(N-Boc-4-piperidine), 4-tetrahydropyran, CH 2 -4-tetrahydropyran, 3-methyl indolyl, 2-naphthyl, 3-pyridyl, 4-pyridyl, 3-thienyl; R 3 is R 2 or C 3-8 alkyl, R 4 is C 1-3 alkyl; and R 5 is NH 2 , OH, NHOH, NHOCH 3 , N(CH 3 )OH, N(CH 3 )OCH 3 , NHCH 2 CH 3 , NH(CH 2 CH 3 ), NHCH 2 (2,4-(OCH3) 2 Ph, NHCH 2 (4-NO 2 )Ph, NHN(CH 3 ) 2 , proline, or 2-hydroxymethyl pyrrolidine. Additionally, a method for the treatment of a neoplastic disease or for the inhibition of tumor cell growth each comprising the step of administering to an individual in need of such treatment a pharmacologically effective dose of the compounds of the present invention are provided.

    专利号:US-5403937-A
    优先权日:1993-04-30
    标 题 :Process for preparing intermediates for the synthesis of antifungal agents
    发明人:SAKSENA ANIL K; GIRIJAVALLABHAN VIYYOOR M; PIKE RUSSELL E; WANG HAIYAN; LOVEY RAYMOND G; LIU YI-TSUNG; GANGULY ASHIT K; MORGAN WILLIAM B; ZAKS ALEKSEY
    权利人:SCHERING CORP
    摘要:Disclosed is a process for preparing chiral compounds of the formula (I) (I) wherein: X1 and X2 are independently F or Cl; and E is -SO2R2, wherein R2 is C1-C6 alkyl, -C6H4CH3 or -CF3; its enantiomer and racemates thereof, useful in the synthesis of tetrahydrofuran azole antifungals. Novel compounds of the formula or wherein: X1 and X2 are independently F or Cl; B represents -C(O)Q* or -CH2OR''; Q* represents a chiral auxiliary group; R'' represents a hydroxy protecting group selected from -CH2C6H5, or -C(O)R1, wherein R1 is C1-C6 alkyl; and A represents Cl, Br, I or triazolyl; are also disclosed.

    专利号:US-5668164-A
    优先权日:1996-07-12
    标 题:Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds
    发明人:MA ZHENKUN; COOPER CURT S; FUNG ANTHONY K L; CHU DANIEL T
    权利人:ABBOTT LAB
    摘要:Process for preparation of chiral cis-3,4-substituted pyrrolidine compounds having the formulas: ##STR1## and chiral 3,4-trans-substituted pyrrolidine compounds having the formulas: ##STR2## with the assistance of a streochemically directing chiral oxazolidinone moiety having the formula: ##STR3## wherein P, R and R 1 are specifically defined, by sequential reaction of the compound or subsequent intermediates with an a,b-unsaturated add chloride, reaction with N-benzyl-N-(methoxymethyl)trimethyl-silylmethylamine and separating isomers by chromatography, hydrolytic removal of the oxazolidinone moiety, reaction with diphenylphosphoryl azide and triethylamine, and debenzylating; and novel intermediates of the process.

    专利号:US-9845299-B2
    优先权日:2013-01-14
    标 题 :Process for the preparation of a fluorolacton derivative
    发明人:CHEN RONGMIN; LI YUANQIANG; ZHAO JIANQIANG; ZHENG JIANBING; ZHU GUOLIANG
    权利人:GILEAD PHARMASSET LLC
    摘要:A novel process for the preparation of a fluorolactone derivative of the formula n n n n n n n n n n n n and of its acylated derivative of formula n n n n n n n n n n n n n n n n wherein R 1 stands for a hydroxy protecting group is described. n n n n n The acylated fluor lactones of formula V, particularly the benzoyl derivative with R 1 =benzyl are important precursors for the synthesis of prodrug compounds which have the potential to be potent inhibitors of the Hepatitis C Virus (HCV) NS5B polymerase.
    济南大宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
    通信地址: 济南市天桥区新材料交易产业园区西副楼
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市天桥区新材料交易产业园区西副楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏万年长药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.wncpharm.com
    企业联系电话:13404202780👤
    📞江苏万年长药业有限公司 ⚠️参考联系方式
    联系人:邓女士
    电话:13404202780
    手机:13404202780
    传真:0513-84818698
    邮箱:wnc@wncpharm.com
    通信地址: 江苏省如东县洋口化工园区内
    邮编: 226000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省如东县洋口化工园区内
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Lu, S.-M.; Zhou, Y.-G., Science of Synthesis: Stereoselective Synthesis, (2011) 1, 280.
    摘要:Klapars, A., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 243.
    摘要:Elliott, M. C.; Jones, D. H., Science of Synthesis: Multicomponent Reactions, (2013) 2, 263.
    摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2026).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知